We suggested earlier that the BRCA1 mutation carrier state in humans, in spite of its association with increased cancer risk, might confer some phenotypic advantages such as reduced predisposition to bone fractures due to increased estrogen exposure [6]. The gene discussed is BRCA1; the disease is cancer.